Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
Novartis
Novartis
Eli Lilly and Company
AbbVie
Canadian Cancer Trials Group
Nektar Therapeutics
Incyte Corporation
Gilead Sciences
Rutgers, The State University of New Jersey